PRODRUGS VON STAT3-INHIBITOREN

European patent · EP4539936 · In force

Register entry

Publication number
EP4539936
Application number
EP23738403
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 9, 2023
Published
Apr 23, 2025
Granted
Aug 19, 2026
Protection ends at the latest
Jun 8, 2043
Next annual fee due
Jun 30, 2027
IPC classes
C07F 9/12 (2006.01)
C07F 9/6574 (2006.01)
A61P 35/00 (2006.01)
C07C 311/29 (2006.01)
C07D 207/09 (2006.01)
Priority
US 202263366437 P 15.06.2022
PCT application
PCT/US2023/068240 09.06.2023
PCT publication
WO2023/244946 21.12.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 30, 2026

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 30.09.2026

  2. Aug 26, 2026

    Change

    Published in Swissreg on 26.08.2026

  3. Aug 19, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.08.2026

Parties

Inventor

ALIBHAI, Imran

Sugar Land, Texas 77478, US

DE ACHAVAL, Sofia

Sugar Land, Texas 77478, US

LARSON, Jeffrey

Sugar Land, Texas 77478, US

HENKE, Brad

Raleigh, North Carolina 27609, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.